Publication | Open Access
Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research
134
Citations
29
References
2018
Year
Experience with checkpoint inhibitors in solid organ transplant recipients is limited. Published cases so far suggest severe risks for graft loss as high as 36% to 54%.
| Year | Citations | |
|---|---|---|
Page 1
Page 1